Table 1.
Characteristics of Persons With HIV in 5 Cohorts of the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD), 2008–2018
| Hospitalized Persons With HIV |
All Persons With HIV in Care |
|||||
|---|---|---|---|---|---|---|
| Characteristica | All (n = 6781) | 2008 (n = 1022) | 2018 (n = 1050) | All (n = 28 381) | 2008 (n = 10 615) | 2018 (n = 16 794) |
|
| ||||||
| Gender | ||||||
| Cisgender men | 5109 (75%) | 726 (71%) | 793 (76%) | 23 277 (82%) | 8655 (82%) | 13 622 (81%) |
| Cisgender women | 1602 (24%) | 283 (28%) | 242 (23%) | 4885 (17%) | 1890 (18%) | 3049 (18%) |
| Transgender persons | 70 (1%) | 13 (1%) | 15 (1%) | 219 (1%) | 70 (1%) | 123 (1%) |
| Race/ethnicity | ||||||
| White | 2704 (40%) | 387 (38%) | 401 (38%) | 11 132 (39%) | 4698 (44%) | 6444 (38%) |
| Black | 2573 (38%) | 430 (42%) | 437 (42%) | 9154 (32%) | 3154 (30%) | 5639 (34%) |
| Hispanic | 918 (14%) | 111 (11%) | 153 (15%) | 4780 (17%) | 1583 (15%) | 2994 (18%) |
| Other or missing | 586 (9%) | 94 (9%) | 59 (6%) | 3315 (12%) | 1180 (11%) | 1717 (10%) |
| Age, y | 48 (40, 56) | 47 (40, 54) | 54 (45, 61) | 43 (34, 51) | 45 (38, 51) | 50 (39, 58) |
| HIV acquisition risk factor | ||||||
| Men who have sex with men | 2997 (44%) | 364 (36%) | 452 (43%) | 15 503 (55%) | 5722 (54%) | 9106 (54%) |
| Injection drug use | 1251 (18%) | 276 (27%) | 188 (18%) | 3385 (12%) | 1510 (14%) | 1755 (10%) |
| Heterosexual, other, or missing | 2533 (37%) | 382 (37%) | 410 (39%) | 9493 (33%) | 3383 (32%) | 5933 (35%) |
| CD4 count, cells/μL | 404 (191, 630) | 294 (109, 510) | 463 (246, 725) | 457 (273, 660) | 440 (279, 623) | 634 (436, 857) |
| HIV RNA <200 copies/mL | 4073 (61%) | 478 (47%) | 813 (79%) | 14 392 (54%) | 6238 (63%) | 13 611 (88%) |
| History of AIDS-defining illness | 1893 (28%) | 430 (42%) | 406 (39%) | 3663 (13%) | 2772 (26%) | 3667 (22%) |
| Body mass indexb kg/m2 | ||||||
| <18.5 kg/m2 | 295 (5%) | 54 (6%) | 52 (5%) | 637 (2%) | 202 (2%) | 234 (2%) |
| 18.5–24.9 kg/m2 | 2636 (41%) | 424 (45%) | 362 (36%) | 10 887 (42%) | 3979 (42%) | 5036 (33%) |
| 25.0–29.9 kg/m2 | 2101 (33%) | 300 (32%) | 337 (33%) | 9525 (36%) | 3534 (37%) | 5794 (38%) |
| ≥30.0 kg/m2 | 1421 (22%) | 173 (18%) | 266 (26%) | 5156 (20%) | 1779 (19%) | 4357 (28%) |
| Cohort enrollment year | 2008 (2003, 2012) | 2004 (2000, 2007) | 2011 (2005, 2015) | 2010 (2006, 2015) | 2004 (2001, 2007) | 2012 (2007, 2016) |
| Enrolled in US-based cohort | 5991 (88%) | 915 (90%) | 934 (89%) | 25 596 (90%) | 9395 (89%) | 14 832 (88%) |
Data are presented as n (%) or median (IQR). Shown are PWH in care who had at least 1 hospitalization (left) and all PWH in care (right), overall and at the beginning and end of the study period.
Abbreviations: HIV, human immunodeficiency virus; IQR, interquartile range; PWH, persons with HIV.
a
Characteristics were measured on 1 January of the calendar of the first hospitalization in the study period for the first column and on 1 January of the relevant year for the second and third columns.
b
Body mass index values were missing for 328, 71, 33, 2176, 1121, and 1373 PWH across columns.